Synthorx, Inc. IPO Research Information

Synthorx, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Synthorx, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Synthorx, Inc.	THOR - NASDAQ	$10.00-$12.00	$11.00	$15.40	11.9 million	12/7/2018
Underwriter(s): Jefferies, Leerink, Evercore ISI
Co-Manager(s): HC Wainwright
Industry: Health Care
Filing(s): Filed 2018-11-13 Terms Added 2018-11-27

Synthorx, Inc. Quote & Chart - Click for current quote - THOR

About Synthorx, Inc. (adapted from Synthorx, Inc. prospectus):
They are a biopharmaceutical company focused on prolonging and improving the lives of people with cancer and autoimmune disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "THOR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.